What is the recommended treatment regimen for brucellosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Brucellosis

First-Line Treatment for Uncomplicated Brucellosis in Adults

The optimal treatment for uncomplicated brucellosis is doxycycline 100 mg twice daily orally for 6 weeks combined with streptomycin 15 mg/kg daily intramuscularly for 2-3 weeks, as this regimen demonstrates the lowest relapse rates. 1, 2, 3

Primary Recommended Regimens (in order of preference):

1. Doxycycline-Streptomycin (DOX-STR) - Preferred regimen:

  • Doxycycline 100 mg twice daily orally for 6 weeks 1, 2
  • Streptomycin 15 mg/kg daily (maximum 1 g) intramuscularly for 2-3 weeks 1, 4
  • This combination has the lowest relapse rates (5-10%) compared to other regimens 5, 6
  • Streptomycin should be injected in the upper outer quadrant of the buttock or mid-lateral thigh, with alternating injection sites 4

2. Doxycycline-Gentamicin (DOX-GENT) - Preferred alternative:

  • Doxycycline 100 mg twice daily orally for 6 weeks 1, 2
  • Gentamicin 5 mg/kg daily parenterally as a single dose for 7 days 1, 2
  • Offers comparable efficacy to DOX-STR with relapse rates of 10-20% 1, 5
  • Advantages include wider availability of gentamicin and sparing streptomycin for tuberculosis treatment 1, 2
  • Important: Use weight-based dosing (5 mg/kg), not fixed 500 mg doses 2

3. Doxycycline-Rifampicin (DOX-RIF) - Second-choice regimen:

  • Doxycycline 100 mg twice daily orally for 6 weeks 1, 2
  • Rifampicin 600-900 mg daily as a single morning dose for 6 weeks 1, 2
  • This regimen has higher relapse rates (15-30%) compared to aminoglycoside-containing regimens 5, 6
  • Critical caveat: In regions where tuberculosis is endemic, avoid rifampicin to prevent mycobacterial resistance 2, 3

Alternative Regimens for Specific Situations

Trimethoprim-Sulfamethoxazole (TMP-SMX) combinations:

  • TMP-SMX 800+160 mg twice daily for 6 weeks combined with rifampicin 1, 7
  • May be used as a cost-effective alternative in resource-limited settings 2
  • Monotherapy with TMP-SMX shows unacceptably high relapse rates (46%) and should be avoided 1

Quinolone-containing regimens:

  • Ofloxacin 400 mg twice daily or ciprofloxacin 500 mg twice daily for 6 weeks in combination with doxycycline 1
  • Should be reserved as second or third agents due to higher cost and risk of promoting antimicrobial resistance 2, 7
  • Not recommended for routine use to preserve efficacy against respiratory pathogens 1

Treatment of Complicated Brucellosis

Brucellar spondylitis (spinal involvement):

  • Aminoglycoside-containing regimens (DOX-STR or DOX-GENT) may be superior to rifampicin-containing regimens 8, 3
  • Treatment duration may need extension beyond 6 weeks 3
  • MRI should be performed when spinal involvement is suspected 8
  • Immobilization of the spine is crucial if cervical involvement is present 8

Neurobrucellosis:

  • If ceftriaxone cannot be used, combine doxycycline and rifampicin with an aminoglycoside (preferably gentamicin over streptomycin) 8

Brucellar endocarditis:

  • Requires aggressive management with empirical antimicrobial selection and surgical intervention in most cases 3
  • High mortality complication requiring combination therapy 3

Special Populations

Pregnant women:

  • Rifampicin 900 mg once daily for 6 weeks is considered the drug of choice 9
  • Tetracyclines are contraindicated 9

Children < 8 years old:

  • Rifampicin combined with TMP-SMX for 45 days is the preferred regimen 9, 7
  • Alternative: Rifampicin for 45 days with gentamicin 5-6 mg/kg/day for the first 5 days 9
  • Tetracyclines are contraindicated 9

Patients > 60 years old:

  • Reduce streptomycin dosage due to increased risk of toxicity 4

Treatment Monitoring and Expected Outcomes

Relapse rates:

  • Even with appropriate treatment, relapse rates range from 5-15% in uncomplicated cases 2, 3
  • Relapses are usually mild and can be treated successfully with the same regimens 2, 3
  • Monotherapy shows significantly higher relapse rates (13% vs. 4.8%) compared to combination therapy 7
  • Short-term treatment (< 4 weeks) shows unacceptably high relapse rates (22% vs. 4.8%) 7

Treatment duration:

  • Standard duration is 6 weeks for uncomplicated cases 1, 2, 3
  • Complicated cases may require 3-6 months of therapy 10

Common Pitfalls to Avoid

  • Never use monotherapy (except rifampicin in pregnancy) - relapse rates are unacceptably high 1, 7
  • Never shorten treatment duration below 6 weeks for uncomplicated cases 7
  • Avoid fixed-dose gentamicin - always use weight-based dosing (5 mg/kg) 2
  • Do not use rifampicin in TB-endemic areas without considering public health implications 2, 3
  • Monitor for ototoxicity with aminoglycosides, especially in elderly patients 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Brucellosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Brucellosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Neurobrucellosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Antibiotic treatment of brucellosis].

Presse medicale (Paris, France : 1983), 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.